SEC Form D · Amendment · filed February 11, 2021
Dialectic Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (14)
Joshua D. Sills · Dallas, TXExecDavid Genecov · Dallas, TXExec · DirectorRobert Hromas · Dallas, TXDirectorJohn D. Harkey · Dallas, TXDirectorDaohong Zhou · Waldo, FLDirectorStephen Cash · New York, NYExecJanelle Maiocco · SEATTLE, WAExec · DirectorKathy Chill · SEATTLE, WADirectorJames Maiocco · SEATTLE, WADirectorDan Schulte · Overland Park, KSExecDaniel Mafrice · Nashville, TNDirectorCarl Farrell · Encino, Los Angeles, CAExec · DirectorSajid Premji · Encino, Los Angeles, CADirectorDaohong Zhou · Waldo, FLDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗